PEAK6 Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.53M Buy
34,557
+7,010
+25% +$349K 0.01% 1587
2018
Q1
$1.34M Buy
+27,547
New +$1.38M 0.01% 1693
2017
Q1
Sell
-318
Closed -$9.57K 4351
2016
Q4
$7K Sell
318
-53,320
-99% -$1.09M ﹤0.01% 4553
2016
Q3
$858K Buy
53,638
+47,855
+828% +$547K 0.01% 1904
2016
Q2
$48K Sell
5,783
-27,280
-83% -$243K ﹤0.01% 3876
2016
Q1
$231K Buy
33,063
+22,719
+220% +$114K ﹤0.01% 2999
2015
Q4
$55K Sell
10,344
-5,342
-34% -$34.1K ﹤0.01% 4239
2015
Q3
$101K Buy
+15,686
New +$164K ﹤0.01% 4300

Other funds holding CC

PEAK6 Group's CC Position: Q2 2018 in Review

PEAK6 Group increased its Chemours (CC) stake by 25% in Q2 2018, buying an estimated $349K and bringing the position to 34,557 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1587.

PEAK6 Group first reported a position in CC in Q3 2015 and has held it in 8 quarters since. 558 funds tracked by Wall St. Rank hold CC as of Q2 2018.

  • PEAK6 Group held 34,557 shares of Chemours worth $1.53M as of Q2 2018.
  • PEAK6 Group bought 7,010 Chemours shares in Q2 2018, an estimated $349K.
  • Chemours made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1587 holding.
  • PEAK6 Group first reported a position in Chemours in Q3 2015 and has held it in 8 quarters since.
  • 558 funds tracked by Wall St. Rank held Chemours as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.